EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Clinical trials for EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in slowing lung cancer return
Disease control OngoingThis study tests whether adding berzosertib to standard chemotherapy (topotecan) helps people with relapsed small cell lung cancer live longer without their cancer growing. About 104 participants will receive either the combination or topotecan alone. The goal is to see if blocki…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:55 UTC
-
Triple-Drug cocktail shows promise for tough lung cancers
Disease control OngoingThis study tests a combination of three drugs (niraparib, temozolomide, and atezolizumab) in people with advanced solid tumors or extensive-stage small cell lung cancer that has responded to initial chemotherapy. The goal is to find the safest dose and see if the combination help…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New combo trial offers hope for tough lung cancer
Disease control OngoingThis early-stage trial tests a combination of three drugs—tazemetostat, topotecan, and pembrolizumab—in adults with small cell lung cancer that has returned after treatment. The goal is to find the safest dose and see if the combination can shrink or stabilize the cancer. About 1…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New combo therapy shows promise for aggressive lung cancer
Disease control OngoingThis study tests whether adding talazoparib to atezolizumab helps control extensive-stage small cell lung cancer better than atezolizumab alone. About 103 adults with a specific genetic marker (SLFN11-positive) are participating. The goal is to see if the combination slows cancer…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Brain radiation may be skipped in lung cancer: new trial tests safer monitoring
Disease control OngoingThis study tests whether using MRI brain scans alone to watch for cancer spread is as good as combining MRI with preventive brain radiation in people with small cell lung cancer. The goal is to see if avoiding radiation can reduce side effects and help patients live longer. About…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New cocktail of drugs and radiation shows promise against tough lung cancer
Disease control OngoingThis study tests a mix of drugs (olaparib, durvalumab, carboplatin, etoposide) plus radiation in people with advanced small cell lung cancer that has spread. The goal is to see if this combination is safe and works better than standard treatment. About 63 participants will take p…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New combo aims to boost chemo for tough lung cancer
Disease control OngoingThis early-stage trial tests a new drug called LB-100 combined with standard chemotherapy and immunotherapy for people with untreated extensive-stage small cell lung cancer. The goal is to find the safest dose and see how well the combination works. Only 3 participants were enrol…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 01, 2026 17:58 UTC